Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2003
09/12/2003WO2003074013A1 Use of sugar esters in cosmetic and/or pharmaceutical preparations
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/12/2003WO2003039596B1 Photodynamic therapy for the treatment of hair loss
09/12/2003WO2003039559B1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
09/12/2003WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003007794A3 Invasion complex and methods of targeting
09/12/2003WO2002066071A3 Treatment of tissue fibrosis by blocking the sp1 transcription factor
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002043686A3 Acid cosmetic, dermatological and pharmaceutical agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects
09/12/2003CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477075A1 Pharmaceutical and cosmetic compositions comprising plgf-1
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003WO2003074075A1 Pharmaceutical and cosmetic compositions comprising plgf-1
09/11/2003US20030171585 Anti-inflammatory compounds
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
09/11/2003US20030171409 Novel delta dicarbonyl compounds and methods for using the same
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171388 Vitamins injected into gel spheres of various colors; mixture of orotic acid and carnitine
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/11/2003US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24.
09/11/2003US20030171340 Treating antibiotic-resistant infections with a metal complex of tetracycline, glycylcycline, or quinolone antibiotics, or administering a metal compound and the antibiotic together for in situ formation of the complex
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171331 Oxazolidinone cotherapy
09/11/2003US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
09/11/2003US20030171281 Therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, in the treatment of microorganism-caused infections, which infections may be systemic, such as a
09/11/2003US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the
09/11/2003US20030171271 Therapeutic application in the treatment of conditions including cancer, macular degeneration and retinopathies. Also included are methods of treating a patient having a pathological condition characterized by an increase in
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170892 For therapeutic treatment of skin wounds,testing of skin anatomy or physiology
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170331 Plant extract of the olea europaea as no-synthase inhibitor and uses
09/11/2003US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter
09/11/2003US20030170297 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin
09/11/2003US20030170280 Particles comprising porous and/ or polycrystalline silicon or multilayer porous silicon oxide mirrors; sunscreen agents
09/11/2003US20030170265 Use of grifola frondosa fungus extracts
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170218 Fungicide and method for producing the same
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003US20030170199 For care and prevention of the signs of ageing of the skin
09/11/2003US20030170191 Hair growth stimulant compositions with sustained action
09/11/2003US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood
09/10/2003EP1343013A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents.
09/10/2003EP1342787A2 Arachidonic acid and methods for the production and use thereof
09/10/2003EP1342474A1 The use of proline, poly-proline peptides and proline-rich proteins to quench reactive oxygen species
09/10/2003EP1342473A1 Esters of vitamin E as products for topical application
09/10/2003EP1342471A1 Nanocapsules based on polyol polyester, and cosmetic and dermatological compositions containing same
09/10/2003EP1342462A1 O/w emulsion composition and method of preparing the same
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1341745A1 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage
09/10/2003EP1341551A2 Treatment of posterior capsule opacification
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341535A2 Skin whiteners containing hydroxytetronic acid
09/10/2003EP1341517A1 A skin cream composition
09/10/2003EP1341515A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1094813B1 Use of piperine and derivatives thereof for treating skin pigmentation disorders and skin cancer
09/10/2003EP1053029B1 Sterile complex of therapeutic peptide bond to a polysaccharide
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP0984938B1 Cyanoguanidines as cell proliferation inhibitors
09/10/2003EP0967957B1 Personal cleansing compositions
09/10/2003EP0921806B1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003CN1441808A Chemokine receptor modulators, production and use
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 1065